Comparison of Utilization and Short-term Complications Between Technology-assisted and Conventional Total Hip Arthroplasty.

Introduction: Although technology-assisted total hip arthroplasty (TA-THA) may improve implant positioning, it remains unknown whether TA-THA confers improved clinical outcomes. We sought to examine national TA-THA utilization trends and compare clinical outcomes between TA-THA and unassisted THA (U-THA).

Methods: Patients who underwent primary, elective THA from 2010 to 2018 were identified using the American College of Surgeons National Surgical Quality Improvement Program database. Demographic, perioperative, and 30-day outcomes were queried and collected. Patients were stratified based on whether they underwent TA-THA, which included computer navigation or robotics, and U-THA. Propensity score matching paired patients undergoing TA-THA or U-THA on a 1:1 basis.

Results: Of the 238,755 THA patients, 3,149 cases (1.3%) were done using TA-THA. Comparing the unmatched TA-THA and U-THA groups, race distribution (P < 0.001) and baseline functional status (P < 0.001) differed. Propensity score matching yielded 2,335 TA-THA and U-THA pairs. Perioperatively, the TA-THA cohort had longer mean surgical times (101.0 ± 34.0 versus 91.9 ± 38.8 minutes, P < 0.001), but lower transfusion rates (5.7% versus 7.8%, P = 0.005). As compared with the U-THA group, the TA-THA group had a shorter mean hospital length of stay (2.0 ± 1.1 versus 2.5 ± 2.0 days, P < 0.001) and a higher proportion of patients discharged home (85.8% versus 75.7%, P < 0.001). Notably, the TA-THA cohort had higher readmission rates (3.8% versus 2.4%, P < 0.001). Major complication and revision surgery rates did not markedly differ between groups.

Discussion: TA-THA utilization rates remain low among orthopaedic surgeons. As compared with U-THA, TA-THA yield mixed perioperative and 30-day outcomes. Surgeons must consider the clinical benefits and drawbacks of TA-THA when determining the proper surgical technique and technology for each patient. Clinical trials assessing long-term functional and clinical outcomes between U-THA and TA-THA are required to further elucidate the utility of assistive technologies in THA.

Level Iii Evidence: Retrospective Cohort Study.